Logo

kidney disease

RenalytixAI, Wake Forest, Atrium Health Partner on Kidney Health Initiative

RenalytixAI will offer its KidneyIntelX platform through Atrium Health's electronic health record system at 37 hospitals across the Carolinas and Georgia.

Renalytix AI Lands US Government Contract for Kidney Disease Test

The firm said that the contract covers early-stage kidney disease testing that can be provided by more than 140 US government departments, agencies, and affiliates.

NephroSant Readies Launch of Kidney Transplant Rejection Assay
Premium

Following the launch of its urine-based Qsant assay later this year, the firm plans to develop updated versions of it with new biomarkers for different disease indications.  

Bio-Techne Seeks to Build Out 'Substantial Diagnostics Presence' With Asuragen Buy
Premium

Bio-Techne expects the acquisition will provide it with a basis to build out its IVD presence, given Asuragen's diagnostic tests and regulatory expertise.

NephroSant Raises $16M in Series A Funding Round

The startup will use the funds to support R&D and to launch its Qsant urine test to help determine if a patient's body is rejecting a kidney transplant.

Feb 24, 2021

RenalytixAI Inks Deal to Introduce Kidney Function Testing Platform at University of Utah Health

Jan 22, 2021

Fresenius Building Large Renal Genomic Registry to Inform Precision Care for Kidney Disease
Premium

Jan 19, 2021

Blood, Urine Biomarker Study Leads to Linked Loci, Disease-Related Risk Scores

Dec 2, 2020

Bio-Techne, Regulus Therapeutics to Develop Assays for Kidney Disease Treatment

Nov 3, 2020

Natera Aims to Improve Prospera Kidney Test After Findings Reveal Cell-Free DNA Changes in Infection
Premium

Aug 21, 2020

RenalytixAI, AstraZeneca Ink Agreement to Enhance Chronic Disease Patient Outcomes

Jun 30, 2020

RenalytixAI Inks Kidney Disease Dx Deals With University of Michigan, Global Pharmaceutical Firm

Jun 12, 2020

RenalytixAI Receives Approval From New York State to Offer Kidney Test

Apr 28, 2020

RenalytixAI, Mount Sinai Launch Study to Predict COVID-19 Kidney Complications
Premium

Mar 18, 2020

Nephrosant Eyes Launch of Urine-Based Kidney Transplantation Rejection Risk Assay
Premium

Mar 17, 2020

Viracor Eurofins, National Kidney Registry Partner to Provide SARS-CoV-2 Testing

Feb 18, 2020

Natera Countersues CareDx for False Advertising

Jan 21, 2020

Urinary Metabolite GWAS Leads to Risk Variants, Potential Markers of Kidney Disease

Jan 8, 2020

Magistrate Judge Recommends Partial Rejection of Natera Motion to Dismiss CareDx False Advertising Lawsuit

Dec 19, 2019

Natera Obtains Final Medicare Local Coverage Determination for Kidney Transplant Test From Palmetto

Dec 6, 2019

Local Coverage Determinations Roundup: Transplant Genomics, Opko Health

Oct 31, 2019

CareDx Q3 Revenues Up 60 Percent

Oct 2, 2019

Liquid Biopsy Test Targets Early Detection of Diabetes Complications, Cancers
Premium

Sep 26, 2019

Human Kidney Immune Cell Map Reveals Multiple Infection Protection Zones

Sep 20, 2019

GWAS in Diabetes Patients Uncovers Risk Loci for Kidney Disease

Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.